Jubilant Pharmova Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 15,847.4 million compared to INR 16,336.8 million a year ago. Revenue was INR 16,126 million compared to INR 16,619 million a year ago. Net income was INR 54.9 million compared to INR 1,428.4 million a year ago. Basic earnings per share from continuing operations was INR 0.34 compared to INR 8.97 a year ago. Diluted earnings per share from continuing operations was INR 0.34 compared to INR 8.97 a year ago.
For the six months, sales was INR 30,252.1 million compared to INR 32,471.3 million a year ago. Revenue was INR 30,756.3 million compared to INR 33,004.4 million a year ago. Net income was INR 525.3 million compared to INR 3,034 million a year ago. Basic earnings per share from continuing operations was INR 3.3 compared to INR 19.06 a year ago. Diluted earnings per share from continuing operations was INR 3.3 compared to INR 19.06 a year ago.